Carl Zeiss Meditec AG

XTRA:AFX Stock Report

Market Cap: €3.8b

Carl Zeiss Meditec Future Growth

Future criteria checks 3/6

Carl Zeiss Meditec is forecast to grow earnings and revenue by 19.8% and 6.2% per annum respectively. EPS is expected to grow by 19.5% per annum. Return on equity is forecast to be 11.3% in 3 years.

Key information

19.8%

Earnings growth rate

19.51%

EPS growth rate

Medical Equipment earnings growth12.7%
Revenue growth rate6.2%
Future return on equity11.28%
Analyst coverage

Good

Last updated21 Aug 2025

Recent future growth updates

Carl Zeiss Meditec AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 10
Carl Zeiss Meditec AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Carl Zeiss Meditec AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 10
Carl Zeiss Meditec AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Carl Zeiss Meditec (ETR:AFX) Could Be Struggling To Allocate Capital

Jul 01
Carl Zeiss Meditec (ETR:AFX) Could Be Struggling To Allocate Capital

Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

May 19
Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

Is It Time To Consider Buying Carl Zeiss Meditec AG (ETR:AFX)?

May 16
Is It Time To Consider Buying Carl Zeiss Meditec AG (ETR:AFX)?

Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 39%?

Apr 28
Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 39%?

Carl Zeiss Meditec (ETR:AFX) Will Pay A Smaller Dividend Than Last Year

Mar 23
Carl Zeiss Meditec (ETR:AFX) Will Pay A Smaller Dividend Than Last Year

Shareholders Will Probably Be Cautious Of Increasing Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation At The Moment

Mar 20
Shareholders Will Probably Be Cautious Of Increasing Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation At The Moment

After Leaping 25% Carl Zeiss Meditec AG (ETR:AFX) Shares Are Not Flying Under The Radar

Mar 15
After Leaping 25% Carl Zeiss Meditec AG (ETR:AFX) Shares Are Not Flying Under The Radar

These 4 Measures Indicate That Carl Zeiss Meditec (ETR:AFX) Is Using Debt Extensively

Mar 03
These 4 Measures Indicate That Carl Zeiss Meditec (ETR:AFX) Is Using Debt Extensively

Carl Zeiss Meditec (ETR:AFX) Might Be Having Difficulty Using Its Capital Effectively

Feb 10
Carl Zeiss Meditec (ETR:AFX) Might Be Having Difficulty Using Its Capital Effectively

More Unpleasant Surprises Could Be In Store For Carl Zeiss Meditec AG's (ETR:AFX) Shares After Tumbling 26%

Jan 10
More Unpleasant Surprises Could Be In Store For Carl Zeiss Meditec AG's (ETR:AFX) Shares After Tumbling 26%

Is Carl Zeiss Meditec AG (ETR:AFX) Potentially Undervalued?

Dec 28
Is Carl Zeiss Meditec AG (ETR:AFX) Potentially Undervalued?
User avatar

AI-Powered Innovations Like KINEVO 900 S And VISUMAX 800 Set To Drive Revenue Growth

New product pipeline and integration of DORC expected to drive revenue and enhance net margins with innovative AI medical solutions.

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Dec 04
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Carl Zeiss Meditec AG's (ETR:AFX) Share Price Could Signal Some Risk

Nov 19
Carl Zeiss Meditec AG's (ETR:AFX) Share Price Could Signal Some Risk

Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital

Sep 19
Some Investors May Be Worried About Carl Zeiss Meditec's (ETR:AFX) Returns On Capital

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Sep 06
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?

Aug 23
Are Investors Undervaluing Carl Zeiss Meditec AG (ETR:AFX) By 27%?

At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Aug 09
At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jul 11
Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Jun 10
Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

May 26
Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 11
Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

May 09
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?

Mar 24
Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Mar 11
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Feb 12
Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jan 29
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Dec 08
What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Nov 08
Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Oct 24
Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Sep 24
Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Sep 08
Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jul 24
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Jun 19
We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Jun 06
Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

May 22
Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Apr 19
Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

Feb 26
Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 10
Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Jan 28
Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Jan 12
Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Dec 29
Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Dec 14
Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Earnings and Revenue Growth Forecasts

XTRA:AFX - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20272,468217221N/A14
9/30/20262,300175198N/A15
9/30/20252,197139133N/A15
6/30/20252,180150N/AN/AN/A
3/31/20252,16915683196N/A
12/31/20242,082157N/AN/AN/A
9/30/20242,06617995247N/A
6/30/20242,066203N/AN/AN/A
3/31/20242,062261122263N/A
12/31/20232,094277N/AN/AN/A
9/30/20232,089290137251N/A
6/30/20232,080308N/AN/AN/A
3/31/20232,02227863162N/A
12/31/20221,963307N/AN/AN/A
9/30/20221,903294106188N/A
6/30/20221,781245N/AN/AN/A
3/31/20221,735264207285N/A
12/31/20211,688228N/AN/AN/A
9/30/20211,647236297363N/A
6/30/20211,566235N/AN/AN/A
3/31/20211,388159240290N/A
12/31/20201,335130N/AN/AN/A
9/30/20201,335122134179N/A
6/30/20201,400120N/AN/AN/A
3/31/20201,507166132171N/A
12/31/20191,505170N/AN/AN/A
9/30/20191,459160173220N/A
6/30/20191,382153N/AN/AN/A
3/31/20191,334129N/A242N/A
12/31/20181,310127N/AN/AN/A
9/30/20181,281126N/A187N/A
6/30/20181,251124N/AN/AN/A
3/31/20181,216129N/A56N/A
12/31/20171,205132N/AN/AN/A
9/30/20171,190134N/A38N/A
6/30/20171,154123N/AN/AN/A
3/31/20171,135112N/A85N/A
12/31/20161,106113N/AN/AN/A
9/30/20161,08898N/A112N/A
6/30/20161,09078N/A132N/A
3/31/20161,08380N/A96N/A
12/31/20151,06261N/A73N/A
9/30/20151,04062N/A57N/A
6/30/201598470N/A34N/A
3/31/201594666N/A44N/A
12/31/201493873N/A60N/A
9/30/201490975N/A63N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AFX's forecast earnings growth (19.8% per year) is above the savings rate (1.4%).

Earnings vs Market: AFX's earnings (19.8% per year) are forecast to grow faster than the German market (16.5% per year).

High Growth Earnings: AFX's earnings are forecast to grow, but not significantly.

Revenue vs Market: AFX's revenue (6.2% per year) is forecast to grow faster than the German market (5.9% per year).

High Growth Revenue: AFX's revenue (6.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: AFX's Return on Equity is forecast to be low in 3 years time (11.3%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/25 11:17
End of Day Share Price 2025/08/25 00:00
Earnings2025/06/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Carl Zeiss Meditec AG is covered by 33 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Scott BardoBerenberg
Julien OuaddourBofA Global Research